ArticlePlastic and reconstructive surgery. Global open2026
Deep Inferior Epigastric Perforator Flap Reconstruction Outcomes Across Body Mass Index Categories: A Retrospective Study.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The impact of body mass index (BMI) on outcomes following deep inferior epigastric perforator (DIEP) flap breast reconstruction remains debated. Although obesity is a well-known risk factor for surgical complications, limited evidence exists on the safety of the DIEP flap across different BMI populations. Methods: We conducted a retrospective study of 117 patients (144 flaps) who underwent DIEP flap breast reconstruction between January 2018 and August 2024. Patients were stratified into 3 BMI groups according to the World Health Organization classification: normal weight, 18.5-25 kg/m Results: Complication rates were generally low across BMI groups. Abdominal seroma ( Conclusions: DIEP flap reconstruction is a safe option for class I and II obese patients. Although higher BMI is associated with increased rates of abdominal seroma and longer hospital stays, overall complication rates remain acceptable. BMI alone should not be considered a contraindication for autologous breast reconstruction in non-morbidly obese patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.